These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 30549142)
1. Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis. Zhu Y; Liu H; Xie N; Liu X; Huang H; Wang C; Hou J Head Neck; 2019 Feb; 41(2):542-550. PubMed ID: 30549142 [TBL] [Abstract][Full Text] [Related]
2. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma. Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754 [TBL] [Abstract][Full Text] [Related]
3. Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer. Mäkitie AA; Almangush A; Rodrigo JP; Ferlito A; Leivo I Head Neck; 2019 Oct; 41(10):3712-3718. PubMed ID: 31328847 [TBL] [Abstract][Full Text] [Related]
4. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma. Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of lymph node ratio in head and neck squamous cell carcinoma. Talmi YP; Takes RP; Alon EE; Nixon IJ; López F; de Bree R; Rodrigo JP; Shaha AR; Halmos GB; Rinaldo A; Ferlito A Head Neck; 2018 May; 40(5):1082-1090. PubMed ID: 29394461 [TBL] [Abstract][Full Text] [Related]
6. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma. Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851 [TBL] [Abstract][Full Text] [Related]
7. Tumor budding to investigate local invasion, metastasis, and prognosis of head and neck carcinoma: A systematic review. Zanoletti E; Daloiso A; Nicolè L; Cazzador D; Mondello T; Franz L; Astolfi L; Marioni G Head Neck; 2024 Mar; 46(3):651-671. PubMed ID: 38013617 [TBL] [Abstract][Full Text] [Related]
8. Tumor budding is a prognostic factor in head and neck squamous cell carcinoma: A comprehensive meta-analysis and trial sequential analysis. Silva FFVE; Caponio VCA; Pérez-Sayáns M; Padín-Iruegas ME; Mascitti M; Chamorro-Petronacci CM; Suaréz-Peñaranda JM; Lorenzo-Pouso AI Crit Rev Oncol Hematol; 2024 Jan; 193():104202. PubMed ID: 37989426 [TBL] [Abstract][Full Text] [Related]
9. Prediction of Occult Lymph Node Metastasis in Head and Neck Cancer with CD31 Vessel Quantification. Mermod M; Bongiovanni M; Petrova T; Goun E; Simon C; Tolstonog G; Monnier Y Otolaryngol Head Neck Surg; 2019 Feb; 160(2):277-283. PubMed ID: 30084319 [TBL] [Abstract][Full Text] [Related]
10. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer. Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692 [TBL] [Abstract][Full Text] [Related]
11. High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma. Li H; Xiao Y; Wu CC; Yang LL; Cao LY; Chen DR; Zhou JJ; Zhang WF; Sun ZJ Histol Histopathol; 2019 Jul; 34(7):803-810. PubMed ID: 30632601 [TBL] [Abstract][Full Text] [Related]
12. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma. Guo YZ; Sun HH; Wang XT; Wang MT J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the nodal yield in head and neck squamous cell carcinoma: A systematic review. de Kort WWB; Maas SLN; Van Es RJJ; Willems SM Head Neck; 2019 Aug; 41(8):2801-2810. PubMed ID: 30969454 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients. Wicker CA; Takiar V; Suganya R; Arnold SM; Brill YM; Chen L; Horbinski CM; Napier D; Valentino J; Kudrimoti MR; Yu G; Izumi T Oral Oncol; 2020 Dec; 111():104949. PubMed ID: 32801084 [TBL] [Abstract][Full Text] [Related]
15. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1). Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857 [TBL] [Abstract][Full Text] [Related]
16. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis. Chen Y; Cong R; Ji C; Ruan W Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589 [TBL] [Abstract][Full Text] [Related]
17. Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma. Jin Y; Qin X Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32076707 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas. González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610 [TBL] [Abstract][Full Text] [Related]
19. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma. Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842 [TBL] [Abstract][Full Text] [Related]
20. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma. Vasan K; Low TH; Gupta R; Ashford B; Asher R; Gao K; Ch'ng S; Palme CE; Clark JR Head Neck; 2018 May; 40(5):993-999. PubMed ID: 29360276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]